MAB21L3
gene geneOn this page
Also known as FLJ38716D5
Summary
MAB21L3 (mab-21 like 3, HGNC:26787) is a protein-coding gene on chromosome 1p13.1, encoding Protein mab-21-like 3 (Q8N8X9).
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 61 total
- MANE Select transcript:
NM_152367
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26787 |
| Approved symbol | MAB21L3 |
| Name | mab-21 like 3 |
| Location | 1p13.1 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ38716, D5 |
| Ensembl gene | ENSG00000173212 |
| Ensembl biotype | protein_coding |
| Entrez | 126868 |
Gene structure
Transcript identifiers
Ensembl transcripts: 7 — 6 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000369500, ENST00000464946, ENST00000683341, ENST00000684484, ENST00000864984, ENST00000864985, ENST00000864986
RefSeq mRNA: 1 — MANE Select: NM_152367
NM_152367
CCDS: CCDS886
Canonical transcript exons
ENST00000369500 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001196500 | 116128145 | 116128339 |
| ENSE00001260466 | 116120932 | 116121072 |
| ENSE00001260486 | 116133132 | 116138149 |
| ENSE00001450187 | 116112407 | 116112663 |
| ENSE00001450188 | 116111629 | 116111810 |
| ENSE00003552010 | 116124066 | 116124357 |
| ENSE00003635772 | 116127466 | 116127644 |
| ENSE00003920529 | 116111399 | 116111510 |
Expression profiles
Bgee: expression breadth broad, 92 present calls, max score 84.61.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0815 / max 14.0316, expressed in 35 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 4806 | 0.0243 | 11 |
| 4809 | 0.0216 | 11 |
| 4807 | 0.0192 | 8 |
| 4808 | 0.0164 | 5 |
Top tissues by expression
206 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| esophagus squamous epithelium | UBERON:0006920 | 84.61 | gold quality |
| esophagus mucosa | UBERON:0002469 | 72.96 | gold quality |
| oral cavity | UBERON:0000167 | 68.49 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 67.26 | gold quality |
| rectum | UBERON:0001052 | 65.58 | gold quality |
| buccal mucosa cell | CL:0002336 | 62.09 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 61.54 | gold quality |
| skin of abdomen | UBERON:0001416 | 60.81 | gold quality |
| zone of skin | UBERON:0000014 | 60.69 | gold quality |
| skin of leg | UBERON:0001511 | 60.29 | gold quality |
| vagina | UBERON:0000996 | 60.01 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 57.84 | silver quality |
| skin of hip | UBERON:0001554 | 57.74 | gold quality |
| amniotic fluid | UBERON:0000173 | 56.60 | silver quality |
| adult mammalian kidney | UBERON:0000082 | 56.22 | gold quality |
| bone marrow cell | CL:0002092 | 53.69 | gold quality |
| tonsil | UBERON:0002372 | 53.23 | gold quality |
| esophagus | UBERON:0001043 | 52.81 | gold quality |
| pharyngeal mucosa | UBERON:0000355 | 52.11 | silver quality |
| kidney | UBERON:0002113 | 51.65 | gold quality |
| urinary bladder | UBERON:0001255 | 51.40 | gold quality |
| liver | UBERON:0002107 | 50.71 | gold quality |
| transverse colon | UBERON:0001157 | 50.64 | gold quality |
| cortex of kidney | UBERON:0001225 | 50.33 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 50.26 | gold quality |
| colonic epithelium | UBERON:0000397 | 50.09 | gold quality |
| right lobe of liver | UBERON:0001114 | 49.94 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 49.63 | gold quality |
| minor salivary gland | UBERON:0001830 | 49.00 | gold quality |
| blood | UBERON:0000178 | 48.90 | gold quality |
Single-cell (SCXA)
Detected in 41 experiment(s), a significant marker in 27.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-137537 | yes | 12931.96 |
| E-GEOD-150728 | yes | 10515.50 |
| E-MTAB-8205 | yes | 5752.71 |
| E-GEOD-124263 | yes | 5749.16 |
| E-MTAB-6678 | yes | 5512.91 |
| E-HCAD-56 | yes | 5139.47 |
| E-GEOD-134144 | yes | 4500.55 |
| E-HCAD-31 | yes | 3975.19 |
| E-CURD-79 | yes | 3626.44 |
| E-MTAB-8894 | yes | 3310.57 |
| E-MTAB-8381 | yes | 2790.95 |
| E-CURD-88 | yes | 2413.12 |
| E-MTAB-10018 | yes | 2325.32 |
| E-GEOD-130473 | yes | 2289.16 |
| E-MTAB-10283 | yes | 1929.18 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
96 targeting MAB21L3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-9-5P | 100.00 | 72.28 | 2361 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-5196-5P | 100.00 | 67.98 | 2761 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-1250-3P | 99.96 | 70.04 | 4038 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-101-3P | 99.94 | 75.03 | 2230 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
| HSA-MIR-548AD-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AE-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548AK | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AM-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AP-5P | 99.94 | 71.14 | 3489 |
| HSA-MIR-548AQ-5P | 99.94 | 71.34 | 3426 |
| HSA-MIR-548AR-5P | 99.94 | 71.28 | 3515 |
| HSA-MIR-548AS-5P | 99.94 | 71.22 | 3482 |
| HSA-MIR-548AU-5P | 99.94 | 71.24 | 3488 |
| HSA-MIR-548AY-5P | 99.94 | 71.23 | 3502 |
| HSA-MIR-548B-5P | 99.94 | 71.23 | 3502 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mab21l3 | ENSDARG00000076013 |
| mus_musculus | Mab21l3 | ENSMUSG00000044313 |
| rattus_norvegicus | Mab21l3 | ENSRNOG00000016044 |
Paralogs (9): ITPRIP (ENSG00000148841), CGAS (ENSG00000164430), MAB21L4 (ENSG00000172478), MB21D2 (ENSG00000180611), MAB21L1 (ENSG00000180660), TMEM102 (ENSG00000181284), MAB21L2 (ENSG00000181541), ITPRIPL1 (ENSG00000198885), ITPRIPL2 (ENSG00000205730)
Protein
Protein identifiers
Protein mab-21-like 3 — Q8N8X9 (reviewed: Q8N8X9)
All UniProt accessions (1): Q8N8X9
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the mab-21 family.
RefSeq proteins (1): NP_689580* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR024810 | MAB21L/cGLR | Family |
| IPR046903 | Mab-21-like_nuc_Trfase | Domain |
| IPR046906 | Mab-21_HhH/H2TH-like | Domain |
Pfam: PF03281, PF20266
UniProt features (2 total): chain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N8X9-F1 | 90.49 | 0.76 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 0 (showing top):
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
Protein interactions and networks
STRING
418 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MAB21L3 | MB21D2 | Q8IYB1 | 602 |
| MAB21L3 | GMNC | A6NCL1 | 493 |
| MAB21L3 | LARP6 | Q9BRS8 | 488 |
| MAB21L3 | AKAIN1 | P0CW23 | 480 |
| MAB21L3 | MCIDAS | D6RGH6 | 458 |
| MAB21L3 | SLC22A15 | Q8IZD6 | 438 |
| MAB21L3 | FAM184B | Q9ULE4 | 433 |
| MAB21L3 | RFX4 | Q33E94 | 433 |
| MAB21L3 | TMEM109 | Q9BVC6 | 384 |
| MAB21L3 | ROGDI | Q9GZN7 | 384 |
| MAB21L3 | GAREM2 | Q75VX8 | 372 |
| MAB21L3 | CCDC71 | Q8IV32 | 366 |
| MAB21L3 | ITPRIPL2 | Q3MIP1 | 365 |
| MAB21L3 | TENT5D | Q8NEK8 | 346 |
| MAB21L3 | TENT5B | Q96A09 | 344 |
IntAct
99 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| STAC3 | MAB21L3 | psi-mi:“MI:0915”(physical association) | 0.780 |
| MAB21L3 | STAC3 | psi-mi:“MI:0915”(physical association) | 0.780 |
| AGGF1 | MAB21L3 | psi-mi:“MI:0915”(physical association) | 0.740 |
| LZTS2 | MAB21L3 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MAB21L3 | LZTS2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| MAB21L3 | EMD | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRTAP10-9 | MAB21L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAB21L3 | AGGF1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PHC2 | MAB21L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FAM9B | MAB21L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MED4 | MAB21L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| EMD | MAB21L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAB21L3 | KRTAP10-9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AGGF1 | MAB21L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAB21L3 | PHC2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAB21L3 | MED4 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LENG1 | MAB21L3 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (33): MAB21L3 (Two-hybrid), MAB21L3 (Two-hybrid), MAB21L3 (Two-hybrid), MAB21L3 (Two-hybrid), MAB21L3 (Two-hybrid), FAM9B (Two-hybrid), STAC3 (Two-hybrid), KRTAP10-9 (Two-hybrid), AHCYL1 (Affinity Capture-MS), MAB21L3 (Two-hybrid), MAB21L3 (Two-hybrid), MAB21L3 (Two-hybrid), MAB21L3 (Two-hybrid), MAB21L3 (Two-hybrid), MAB21L3 (Two-hybrid)
ESM2 similar proteins: A2ASA8, A2CI98, A2CJ06, A4IG61, A4IIW0, A7MB64, A8E4S7, O15482, P59025, P79621, Q08AI8, Q0IES7, Q0IES8, Q0V9X7, Q29H55, Q29H56, Q3TNL8, Q3UJB3, Q3UPR7, Q567X9, Q569B5, Q5MYT7, Q5QGT7, Q5TW90, Q640Z9, Q66H52, Q6DCQ5, Q6GNM3, Q6GPH6, Q6GQ81, Q6GQD9, Q6NYB4, Q7QHX4, Q80VA5, Q80ZF2, Q80ZI2, Q8BPP1, Q8C8C1, Q8CEZ4, Q8CI17
Diamond homologs: A0A2B4RP11, A8E4S7, Q29H55, Q6GNM3, Q8CI17, Q8N8X9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
61 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 53 |
| Likely benign | 3 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
786 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:116128337:CAGGT:C | donor_loss | 1.0000 |
| 1:116128339:GGT:G | donor_loss | 1.0000 |
| 1:116128340:GT:G | donor_loss | 1.0000 |
| 1:116128341:T:G | donor_loss | 1.0000 |
| 1:116130591:A:T | donor_gain | 1.0000 |
| 1:116133126:CCACA:C | acceptor_loss | 1.0000 |
| 1:116133127:CACA:C | acceptor_loss | 1.0000 |
| 1:116133130:A:AG | acceptor_gain | 1.0000 |
| 1:116133130:A:T | acceptor_loss | 1.0000 |
| 1:116133131:G:GA | acceptor_gain | 1.0000 |
| 1:116133131:GA:G | acceptor_gain | 1.0000 |
| 1:116133131:GAC:G | acceptor_gain | 1.0000 |
| 1:116133131:GACT:G | acceptor_gain | 1.0000 |
| 1:116112394:A:AG | acceptor_gain | 0.9900 |
| 1:116121070:AAGG:A | donor_loss | 0.9900 |
| 1:116121071:AGGT:A | donor_loss | 0.9900 |
| 1:116121073:G:GA | donor_loss | 0.9900 |
| 1:116121074:T:G | donor_loss | 0.9900 |
| 1:116124057:T:A | acceptor_gain | 0.9900 |
| 1:116124063:TA:T | acceptor_loss | 0.9900 |
| 1:116124064:A:AG | acceptor_gain | 0.9900 |
| 1:116124064:A:C | acceptor_loss | 0.9900 |
| 1:116124065:G:GG | acceptor_gain | 0.9900 |
| 1:116124317:G:GT | donor_gain | 0.9900 |
| 1:116124354:TCAGG:T | donor_loss | 0.9900 |
| 1:116124355:CAGG:C | donor_loss | 0.9900 |
| 1:116124357:GGT:G | donor_loss | 0.9900 |
| 1:116127446:ATTT:A | acceptor_gain | 0.9900 |
| 1:116127449:T:TA | acceptor_gain | 0.9900 |
| 1:116128143:A:AG | acceptor_gain | 0.9900 |
AlphaMissense
2374 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:116128184:T:A | W234R | 0.990 |
| 1:116128184:T:C | W234R | 0.990 |
| 1:116121029:T:C | F49S | 0.987 |
| 1:116121028:T:C | F49L | 0.984 |
| 1:116121030:T:A | F49L | 0.984 |
| 1:116121030:T:G | F49L | 0.984 |
| 1:116124252:T:A | W126R | 0.984 |
| 1:116124252:T:C | W126R | 0.984 |
| 1:116124292:C:A | P139H | 0.984 |
| 1:116128295:T:A | W271R | 0.983 |
| 1:116128295:T:C | W271R | 0.983 |
| 1:116128186:G:C | W234C | 0.979 |
| 1:116128186:G:T | W234C | 0.979 |
| 1:116133220:T:C | L315P | 0.979 |
| 1:116128250:C:A | R256S | 0.978 |
| 1:116128335:T:C | L284P | 0.978 |
| 1:116124097:T:A | V74D | 0.977 |
| 1:116133177:T:A | W301R | 0.976 |
| 1:116133177:T:C | W301R | 0.976 |
| 1:116133179:G:C | W301C | 0.976 |
| 1:116133179:G:T | W301C | 0.976 |
| 1:116127612:T:A | W210R | 0.974 |
| 1:116127612:T:C | W210R | 0.974 |
| 1:116124292:C:G | P139R | 0.972 |
| 1:116124231:T:C | F119L | 0.971 |
| 1:116124233:T:A | F119L | 0.971 |
| 1:116124233:T:G | F119L | 0.971 |
| 1:116127591:T:A | W203R | 0.971 |
| 1:116127591:T:C | W203R | 0.971 |
| 1:116121027:A:C | R48S | 0.966 |
dbSNP variants (sampled 300 via entrez): RS1000013150 (1:116110875 A>T), RS1000109836 (1:116132409 G>A,T), RS1000240759 (1:116117285 C>T), RS1000281006 (1:116126090 G>A), RS1000355182 (1:116129205 G>A,C), RS1000365554 (1:116119868 T>C), RS1000426282 (1:116123082 T>C), RS1000552443 (1:116128777 C>T), RS1000554211 (1:116111116 G>A), RS1000588522 (1:116113730 T>A), RS1000621667 (1:116137711 T>C), RS1000893062 (1:116124622 A>G), RS1000977977 (1:116129256 G>T), RS1001008930 (1:116135180 G>A,T), RS1001013481 (1:116136776 G>A,C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005330_3 | Coffee consumption | 8.000000e-07 |
| GCST006976_129 | Macular thickness | 2.000000e-08 |
| GCST011743_30 | HDL cholesterol levels in HIV infection | 6.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006782 | cups of coffee per day measurement |
| EFO:0004612 | high density lipoprotein cholesterol measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
21 total (human), top 21 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | affects methylation, decreases expression, decreases methylation, increases expression, increases mutagenesis | 6 |
| Cyclosporine | decreases expression, increases expression | 4 |
| sodium arsenite | increases expression | 2 |
| Cadmium | increases abundance, decreases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | increases expression | 1 |
| OTX015 | decreases expression | 1 |
| mivebresib | decreases expression | 1 |
| tris(2-butoxyethyl) phosphate | affects expression | 1 |
| avobenzone | decreases expression | 1 |
| tebuconazole | decreases expression | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| jinfukang | decreases expression | 1 |
| (+)-JQ1 compound | decreases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Leflunomide | increases expression | 1 |
| Cisplatin | decreases expression | 1 |
| Diuron | decreases expression | 1 |
| Ethyl Methanesulfonate | increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Cellosaurus cell lines
3 cell lines: 3 embryonic stem cell
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_A3Z5 | SEES3-1V human MAB21L3, clone1 | Embryonic stem cell | Male |
| CVCL_A3Z6 | SEES3-1V human MAB21L3, clone2 | Embryonic stem cell | Male |
| CVCL_A3Z7 | SEES3-1V human MAB21L3, clone3 | Embryonic stem cell | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.